Displaying 1 - 12 of 14
Immune-Mediated and Cholestatic Diseases
Cholestatic Pruritus in Primary Biliary Cholangitis (PBC): Assessment and Management Guide

Cholestatic Pruritus in Primary Biliary Cholangitis (PBC): Assessment and Management Guide

Infographics
View
Immune-Mediated and Cholestatic Diseases
Current Therapies: Patients with PBC Pruritus

Current Therapies: Patients with PBC Pruritus

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Collaborative Care: Strengthening the Healthcare Provider-Patient Partnership in PBC

Collaborative Care: Strengthening the Healthcare Provider-Patient Partnership in PBC

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Elevating Care for Individuals with Pruritus in PBC

Elevating Care for Individuals with Pruritus in PBC

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Living with Cholestatic Pruritus in PBC: A Patient’s Perspective

Living with Cholestatic Pruritus in PBC: A Patient’s Perspective

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Switching focus: Cholestatic Pruritus in PBC

Switching focus: Cholestatic Pruritus in PBC

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Navigating PBC: Effective Strategies for Managing Pruritus and Fatigue

Navigating PBC: Effective Strategies for Managing Pruritus and Fatigue

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Guiding your Patients: Addressing Cholestatic Pruritus in PBC

Guiding your Patients: Addressing Cholestatic Pruritus in PBC

Webcasts
View
Viral Hepatitis
Exploring Functional Cure in Chronic Hepatitis B

Exploring Functional Cure in Chronic Hepatitis B

Webcasts
View
Viral Hepatitis
Quantitative hepatitis B surface antigen (qHBsAg) is a useful biomarker for Chronic Hepatitis B

Quantitative hepatitis B surface antigen (qHBsAg) is a useful biomarker for Chronic Hepatitis B

PDF
View
Viral Hepatitis

GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session)

Webcasts
View